<DOC>
	<DOCNO>NCT00932256</DOCNO>
	<brief_summary>MAGNA intend show combination pseudoephedrine , chlorpheniramine , plus small amount belladonna alkaloid comprehensive , safe effective twice daily ( BID ) drug treatment seasonal allergic rhinitis ( SAR ) patient post-nasal drip ( PND ) . The phase 1 single-dose trial consist 21 subject : 1 ) gather pharmacodynamic measurement blood level active ingredient 12 hour ; 2 ) To report subjective score subject rating efficacy single dose STAHIST ; 3 ) To report side effect adverse drug reaction rate severity incidence .</brief_summary>
	<brief_title>Clinical Trial STAHIST Seasonal Allergic Rhinitis Patients</brief_title>
	<detailed_description>No procedure perform Informed Consent obtain . Inclusion exclusion criterion verify . Subjects require stop use oral nasal decongestant first generation antihistamine 48 hour , second generation antihistamine Singulair seven day , systemic corticosteroid 30 day , nasal ocular corticosteroid medication two week . Use drug allow study . Blood sample draw specific time point : baseline fast blood draw 7AM , 9 AM , 11AM , 3PM , 7PM . A single oral dose STAHIST administer 7AM . During study diary five study symptom ( S5 Diary ) score hourly 12-hour period follow : 0 none , 1 mild , 2 moderate , 3 severe . The S5 symptom 1 . Nasal Congestion ( Stuffiness ) ; 2 . Sneezing ; 3 . Rhinorrhea ( runny nose ) ; 4 . Nasal Itching ; 5 . Post-nasal drip . Post nasal drip define patient `` feel accumulated mucus drip back throat sinus , also possibly include tickly cough sore throat due sensation mucus . '' Side effect adverse drug reaction score occur hourly 1 mild , 2 moderate , 3 severe . Any adverse event record . Any subject able unwilling continue keep diary participate blood draw permit withdraw study . Safety assure frequent visible assessment question subject well monitor subject ' vital sign Dr. Pollard nursing staff . Subjects remain clinic 12-hour dosage interval . Thereafter , Dr. Pollard select staff call 24 hour answer subject phone call .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<criteria>Males females ethnic group age 18 60 year age . History moderate severe SAR least one year . Subjects ' symptom include five symptom ( `` S5 '' ) focus study : nasal congestion ; rhinorrhea ; nasal itch ; sneeze ; post nasal drip . Prior study subject ' good health confirm medical history physical examination . Allergic hypersensitivity confirm appropriate test deem necessary physician well establish medical history . Pregnancy lactation . Immunotherapy unless stable maintenance dose . Presence medical condition might interfere treatment evaluation require change therapy include limited high blood pressure urinary retention problem . Alcohol dependence . Use investigational drug previous month . Subjects present asthma require corticosteroid treatment . Subjects multiple drug allergy . Subjects know idiosyncratic reaction ingredient STAHIST .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Rhinitis , Allergic , Seasonal</keyword>
</DOC>